News & Updates

Show Multimedia Only

Aspirin mitigates preterm birth risk linked to heat exposure

20 May 2026

Initiating low-dose aspirin early in pregnancy may reduce the risk of preterm birth associated with heat exposure among nulliparous women, according to a study.

Aspirin mitigates preterm birth risk linked to heat exposure

20 May 2026

Response-adapted chemo-free adjuvant treatment feasible in low-risk HER2+ early breast cancer

20 May 2026 by

A neoadjuvant pathologic complete response-adapted de-escalation strategy to omit chemotherapy in the adjuvant setting is clinically feasible and helps preserve health-related quality of life in highly selected patients with low-risk HER2-positive early breast cancer, according to the phase II PHERGain-2 trial.

Response-adapted chemo-free adjuvant treatment feasible in low-risk HER2+ early breast cancer

20 May 2026

BP shows linear relationship with cardiovascular, renal outcomes in T2D

20 May 2026

Blood pressure (BP) demonstrates a linear or monotonic association with most cardiovascular and renal outcomes in individuals with type 2 diabetes (T2D), reports a study.

BP shows linear relationship with cardiovascular, renal outcomes in T2D

20 May 2026

Organic fruits, vegetables may lower risk of postmenopausal breast cancer

20 May 2026 by

Substituting conventional with organic fruits and vegetable (F&V) appears to reduce the risk of postmenopausal cancer, suggests a study.

Organic fruits, vegetables may lower risk of postmenopausal breast cancer

20 May 2026

Capivasertib‒fulvestrant combo delays second progression, chemo in advanced breast cancer

20 May 2026 by

The addition of capivasertib to fulvestrant improves time to second progression (PFS2) and time to first subsequent chemotherapy or death (TTFSC) in PIK3CA/AKT1/PTEN-altered patients with HR+/HER2- advanced breast cancer and the overall population, suggesting a clinically meaningful benefit when compared with placebo plus fulvestrant, as shown in the phase III CAPItello-291 trial.

Capivasertib‒fulvestrant combo delays second progression, chemo in advanced breast cancer

20 May 2026

Lecanemab continues to delay progression in AD at 4 years

20 May 2026 by

The 48-month analysis of the global phase III Clarity AD study shows that lecanemab continues to deliver benefit and delay progression in early Alzheimer's disease (AD).

Lecanemab continues to delay progression in AD at 4 years

20 May 2026

Novel small-molecule TLR7/8 inhibitor shows therapeutic potential in lupus

20 May 2026

The oral small-molecule TLR7/8 inhibitor enpatoran has shown a dose-dependent effect on disease activity in patients with active skin manifestations of cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) in the phase II WILLOW trial.

Novel small-molecule TLR7/8 inhibitor shows therapeutic potential in lupus

20 May 2026

Achieving repigmentation with ruxolitinib cream in Chinese vitiligo patients

20 May 2026 by

A 37-year-old Chinese man with a 6-year history of vitiligo (onset at age of 25 years) first presented in November 2017 with extensive depigmentation over his nose, mouth, chin, forehead, back of his neck and hands, and the left elbow.

Achieving repigmentation with ruxolitinib cream in Chinese vitiligo patients

20 May 2026

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

19 May 2026 by

In a recent study from Singapore, housing type and sedentary behaviour have emerged as novel risk factors for diabetic peripheral neuropathy.

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

19 May 2026

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

19 May 2026

The use of invasive intracranial pressure monitoring (IICPM) in three high-volume liver transplant centres has declined over 10 years with no associated worsening of outcomes among patients with acute liver failure (ALF), according to a study.

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

19 May 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Aspirin mitigates preterm birth risk linked to heat exposure

Aspirin mitigates preterm birth risk linked to heat exposure

Response-adapted chemo-free adjuvant treatment feasible in low-risk HER2+ early breast cancer

Response-adapted chemo-free adjuvant treatment feasible in low-risk HER2+ early breast cancer

BP shows linear relationship with cardiovascular, renal outcomes in T2D

BP shows linear relationship with cardiovascular, renal outcomes in T2D

Organic fruits, vegetables may lower risk of postmenopausal breast cancer

Organic fruits, vegetables may lower risk of postmenopausal breast cancer

Capivasertib‒fulvestrant combo delays second progression, chemo in advanced breast cancer

Capivasertib‒fulvestrant combo delays second progression, chemo in advanced breast cancer

Lecanemab continues to delay progression in AD at 4 years

Lecanemab continues to delay progression in AD at 4 years

Novel small-molecule TLR7/8 inhibitor shows therapeutic potential in lupus

Novel small-molecule TLR7/8 inhibitor shows therapeutic potential in lupus

Achieving repigmentation with ruxolitinib cream in Chinese vitiligo patients

Achieving repigmentation with ruxolitinib cream in Chinese vitiligo patients

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients

Non-use of intracranial pressure monitoring does not elevate ICH risk in ALF patients